Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates
Olivier Humbert, Stefan Radtke, Clare Samuelson, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 503
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
Mitchell L. Leibowitz, Stamatis Papathanasiou, Phillip A. Doerfler, et al.
Nature Genetics (2021) Vol. 53, Iss. 6, pp. 895-905
Open Access | Times Cited: 424
In vivo somatic cell base editing and prime editing
Gregory A. Newby, David R. Liu
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3107-3124
Open Access | Times Cited: 133
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission
Frédéric B. Piel, David C. Rees, Michael R. DeBaun, et al.
The Lancet Haematology (2023) Vol. 10, Iss. 8, pp. e633-e686
Open Access | Times Cited: 64
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
Yan-Ruide Li, Ying Fang, Shaoqiang Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
Leslie Weber, Giacomo Frati, Tristan Félix, et al.
Science Advances (2020) Vol. 6, Iss. 7
Open Access | Times Cited: 110
In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice
Chang Li, Aphrodite Georgakopoulou, Arpit Mishra, et al.
Blood Advances (2021) Vol. 5, Iss. 4, pp. 1122-1135
Open Access | Times Cited: 69
CRISPR/Cas9 gene editing for curing sickle cell disease
So Hyun Park, Gang Bao
Transfusion and Apheresis Science (2021) Vol. 60, Iss. 1, pp. 103060-103060
Open Access | Times Cited: 68
Comprehensive analysis and accurate quantification of unintended large gene modifications induced by CRISPR-Cas9 gene editing
So Hyun Park, Mingming Cao, Yidan Pan, et al.
Science Advances (2022) Vol. 8, Iss. 42
Open Access | Times Cited: 53
Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin
Nithin Sam Ravi, Beeke Wienert, Stacia K. Wyman, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 51
CRISPR/Cas systems: Delivery and application in gene therapy
Jie Huang, Yitong Zhou, Jie Li, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 49
Potent and uniform fetal hemoglobin induction via base editing
Thiyagaraj Mayuranathan, Gregory A. Newby, Ruopeng Feng, et al.
Nature Genetics (2023) Vol. 55, Iss. 7, pp. 1210-1220
Open Access | Times Cited: 35
Gene Therapy and Gene Editing for β-Thalassemia
Georgios E. Christakopoulos, Rahul Telange, Jonathan Yen, et al.
Hematology/Oncology Clinics of North America (2023) Vol. 37, Iss. 2, pp. 433-447
Open Access | Times Cited: 22
Revolutionising healing: Gene Editing's breakthrough against sickle cell disease
Marija Dimitrievska, Dravie Bansal, Marta Vitale, et al.
Blood Reviews (2024) Vol. 65, pp. 101185-101185
Open Access | Times Cited: 12
Effectiveness of Psychobiotics in the Treatment of Psychiatric and Cognitive Disorders: A Systematic Review of Randomized Clinical Trials
Freiser Eceomo Cruz Mosquera, Santiago Lizcano Martinez, Yamil Liscano
Nutrients (2024) Vol. 16, Iss. 9, pp. 1352-1352
Open Access | Times Cited: 12
Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies
Liren Wang, Linxi Li, Yanlin Ma, et al.
Cell Research (2020) Vol. 30, Iss. 3, pp. 276-278
Open Access | Times Cited: 67
BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Selami Demirci, Jing Zeng, Yuxuan Wu, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6677-6687
Open Access | Times Cited: 61
Nonhuman Primates in Translational Research
Alice F. Tarantal, Stephen C. Noctor, Dennis J. Hartigan-O’Connor
Annual Review of Animal Biosciences (2022) Vol. 10, Iss. 1, pp. 441-468
Open Access | Times Cited: 31
Direct correction of haemoglobin E β-thalassaemia using base editors
Mohsin Badat, Ayesha Ejaz, Hua Peng, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 20
Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells
Malihe Lotfi, Dorsa Morshedi Rad, Samaneh Mashhadi, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 8, pp. 2576-2596
Open Access | Times Cited: 19
The p53 challenge of hematopoietic stem cell gene editing
Sofie R. Dorset, Rasmus O. Bak
Molecular Therapy — Methods & Clinical Development (2023) Vol. 30, pp. 83-89
Open Access | Times Cited: 16
Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Justin S. Antony, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 45
Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primates
Blake J. Rust, Leslie S. Kean, Lucrezia Colonna, et al.
Blood (2020) Vol. 136, Iss. 15, pp. 1722-1734
Open Access | Times Cited: 45
Strategies for the CRISPR-Based Therapeutics
Bin Li, Yuyu Niu, Weizhi Ji, et al.
Trends in Pharmacological Sciences (2019) Vol. 41, Iss. 1, pp. 55-65
Open Access | Times Cited: 44
PLGA-Nanoparticles for Intracellular Delivery of the CRISPR-Complex to Elevate Fetal Globin Expression in Erythroid Cells
Luis J. Cruz, Thamar van Dijk, Olena Vepris, et al.
Biomaterials (2020) Vol. 268, pp. 120580-120580
Open Access | Times Cited: 39
Cas9-directed immune tolerance in humans—a model to evaluate regulatory T cells in gene therapy?
Dimitrios L. Wagner, Lena Peter, Michael Schmueck‐Henneresse
Gene Therapy (2021) Vol. 28, Iss. 9, pp. 549-559
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top